PTC596 是一种口服活性和选择性的 B 细胞特异性莫洛尼氏鼠白血病病毒整合位点 1 (BMI-1) 抑制剂。PTC596 靶向肿瘤细胞和癌症干细胞 (CSC) 均表达的 BMI1，并诱导 BMI1 过度磷酸化，从而导致其降解。PTC596 可下调 MCL-1 并诱导急性髓系白血病祖细胞中不依赖 p53 的线粒体凋亡。
货号:ajcx15024
CAS:1610964-64-1
分子式:C19H13F5N6
分子量：420.34
溶解度:DMF: 30 mg/ml,DMSO: 30 mg/ml,Ethanol: 5 mg/ml
纯度：98%
存储：Store at -20°C
库存：现货

Background:

PTC596 is an orally active and selective B-cell-specific Moloney murine leukemia virus integration site 1 (BMI-1) inhibitor. PTC596 targets BMI1 expressed by both tumor cells and cancer stem cells (CSCs), and induces hyper-phosphorylation of BMI1, leading to its degradation. PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells[1][2].

[1]. Nishida Y, et al. The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells. Blood Cancer J. 2017 Feb 17;7(2):e527. [2]. BMI1 inhibitor PTC596